Skip to main content

Biotechnology Startups

Updated August 2026

Companies in the biotechnology sector developing innovative solutions and technologies.

Explore 5,740 recently funded biotechnology companies with verified founder contact information and fundraising data.

Total Companies
5,740
Total Funding
$817.7M
Avg Funding
$32.7M
Global Reach
6
countries

Top Cities for Biotechnology

Cambridge
Doylestown
Mountain View
Hamburg
Worcester
London

Recently Funded Companies

Export
Cambridge, United States

Terrestrial Bio engages in developing biomedical innovations with a focus on improving access to vaccines.

$50.0M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Doylestown, United States

Pinnacle Medicines is a peptide drug discovery company that provides peptide modality for medical needs.

$89.0M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Mountain View, United States

Heartflow is a medical technology company that provides various methods of diagnosis and treatment of cardiovascular disease.

$98.0M raised
Mar 2025

Founder Contacts

41,000+ verified contacts

Hamburg, Germany

Mo:re is building the new gold standard for organoid-based drug development

$2.5M raised
Mar 2025

Founder Contacts

41,000+ verified contacts

Worcester, United States

3X Genetics develops medical screening solutions to identify genetic disorders.

$3.2M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

London, United Kingdom

Epoch develops natural solutions to unnatural problems. First up: enzymes that transform plastics into circular chemicals.

$12.0M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

León, Spain

53Biologics is a company that are into manufacturing of bio technology and bio development products.

Mar 2026

Founder Contacts

41,000+ verified contacts

London, United Kingdom

NetZeroNitrogen exists to eliminate synthetic nitrogen fertilizer.

Mar 2026

Founder Contacts

41,000+ verified contacts

Stockholm, Sweden

ProteomEdge provides proprietary mass spectrometry platforms for precise, absolute protein quantification of clinically relevant targets.

$858K raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Pacegenix is a healthcare tech company advancing cardiovascular care with data-driven precision medicine solutions.

$22.5M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Berlin, Germany

Cellbricks is a Berlin- and Boston-based biotech, pioneering the future of tissue and organ replacement.

$8.1M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Nalu Bio is a biotechnology company that focuses on a science and data-driven approach to cannabanoid biology.

Mar 2025

Founder Contacts

41,000+ verified contacts

Boston, United States

Hillstar Bio is developing precision immunotherapies to treat autoimmune diseases.

$67.0M raised
Mar 2025

Founder Contacts

41,000+ verified contacts

South San Francisco, United States

Nkarta Therapeutics is a developer of cell engineering platform created to build the next generation of cell therapies.

$240.0M raised
Mar 2024

Founder Contacts

41,000+ verified contacts

Brookline, United States

Edgewood Oncology is promoting a first-in-class therapy for malignancies that are challenging to treat.

$20.0M raised
Mar 2024

Founder Contacts

41,000+ verified contacts

Fort Collins, United States

Axiota Animal Health develops and markets products for beef and dairy producers, including MultiMin 90 and Lactipro.

$30.1M raised
Mar 2024

Founder Contacts

41,000+ verified contacts

Calabasas, United States

Turn Therapeutics is a pharmaceutical company that is dedicated to reducing the human and economic costs of infection and skin disease.

$7.0M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Bozeman, United States

ALERCELL AI-powered epigenetic diagnostic platform detecting leukemia up to 41 months before clinical symptoms.

Mar 2026

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Origin is a biotech company that creates patient-derived cancer single-cell dataset for licensing to pharmaceutical and AI companies.

Mar 2026

Founder Contacts

41,000+ verified contacts

Lund, Sweden

Hamlet BioPharma is a pharmaceutical company with strong links to research.

$967K raised
Mar 2026

Founder Contacts

41,000+ verified contacts

New York, United States

Gilgamesh Pharmaceuticals is a clinical-stage biotechnology company that develops psychedelic and related drugs to treat mental illnesses.

$60.0M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Orange, Australia

Cauldron Ferm is a bio-acceleration process that exponentially scales up any precision fermented prototype to commercial quantities.

$13.3M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United Kingdom

Immutrin is a biotech developing next‑generation antibody therapies to clear amyloid deposits and reverse amyloidosis.

$87.1M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

San Diego, United States

Sinopia Biosciences enables data-driven drug discovery by means of multi-omics data, machine learning, network analyses, and disease models.

$400K raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Barcelona, Spain

Peptomyc focuses on the development of a new generation of cell-penetrating peptides targeting the Myconcoprotein for cancer treatment.

$5.8M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Showing 2451 to 2475 of 5,740 companies

About the Biotechnology Startup Ecosystem

The biotechnology sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biotechnology

Biotechnology companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biotechnology sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biotechnology Funding Breakdown

Here is how funding is distributed among the 5,740 biotechnology companies tracked in the VCBacked database.

Average Funding
$32.7M
Total Funding Tracked
$817.7M
Countries Represented
6

Distribution by Funding Stage

Other25 companies

Top Cities for Biotechnology

1.Cambridge
3 companies$159.6M
2.London
2 companies$12.0M
3.San Francisco
2 companiesUndisclosed
4.Doylestown
1 companies$89.0M
5.Mountain View
1 companies$98.0M

Related Industries

Companies in the biotechnology sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biotechnology Startups?

Perfect for: B2B sales teams targeting biotechnology companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked